Sentences with phrase «cannabis use disorders»

Inattention significantly predicted nicotine, alcohol, and cannabis use disorders, but its contributions mostly overlapped those of HI and CD by 14 years of age.
Hyperactivity / impulsivity significantly predicted nicotine, alcohol, and cannabis use disorders (and remained significantly predictive except for alcohol use disorders) once CD by the age - 14 follow - up was taken into account.
Summary: (To include comparison groups, outcomes, measures, notable limitations) This article presents the main outcome findings from two inter-related randomized trials conducted at 4 sites to evaluate the effectiveness of 5 short - term outpatient interventions for adolescents with cannabis use disorders.
Parental transmission of risk for cannabis use disorders to offspring.
The focus of the research programs in the Laboratory of Clinical Psychopharmacology is the clinical evaluation of potential medications for protracted abstinence and relapse prevention in alcohol use disorder and related disorders such as nicotine and cannabis use disorders.
If the US population remained constant over that time period, the researchers calculate, medical marijuana laws could be linked to 1.1 million additional cannabis users and 500,000 extra people with cannabis use disorder nationwide.
Cannabis use disorder occurs when users» lives are impaired by cravings or withdrawal, for example.
Researchers found that illegal use of marijuana and rates of cannabis use disorder rose to a greater extent in US states that adopted laws legalizing marijuana for medical purposes than in states that didn't adopt such laws.
These GABA neurons may represent a promising new target for treatment of cannabis use disorder, a common condition on the rise in the United States.
«Many adolescents and young adults who are at high risk for psychosis smoke marijuana regularly or have a cannabis use disorder,» said Margaret Haney, PhD, professor of neurobiology (in Psychiatry) at CUMC and senior author of the paper.
The researchers were surprised to see that the prevalence of cannabis and alcohol use disorder in this study was notably higher than national estimates with 21 percent meeting criteria for cannabis use disorder and 20 percent meeting criteria for alcohol use disorder at age 18.
«The findings suggest that if we can prevent or reduce chronic depression during early adolescence, we may reduce the prevalence of cannabis use disorder,» said lead author Isaac Rhew, research assistant professor of psychiatry and behavioral sciences at the University of Washington School of Medicine.
The study suggests that marijuana use — even in the absence of cannabis use disorder (characterized by problematic use of cannabis due to impairment in functioning or difficulty quitting or cutting down on use)-- is associated with increased odds of smoking onset, relapse, and persistence.
As cannabis use is much more common than cannabis use disorder, its potential impact on cigarette use in the general community may be greater than estimates based on studies of cannabis use disorder alone, according to the researchers.
Cannabis use disorder (CUD), replacing previous cannabis abuse and cannabis dependence, might be as common as appearing in one - fifth of regular cannabis users.6 Risk of CUD is higher in those who use more frequently, are male, and begin at a younger age.6, 24 However, in another study of those meeting criteria for having CUD, 67 % remitted (no longer met criteria) at 3 years, with 64 % of them no longer using cannabis.25 Whether regular medical use might result in CUD, what outcomes this might have, and if discontinuation presents concerns are all not well understood.
Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing Multidimensional Family Therapy and Cognitive Behavioral Therapy in the Netherlands.
Summary: (To include comparison groups, outcomes, measures, notable limitations) This study investigated whether Multidimensional Family Therapy (MDFT) was more effective than Cognitive - Behavioral Therapy (CBT) in treatment - seeking adolescents with a DSM - IV cannabis use disorder.
Percentage of adolescents (N = 1359) with a specified number of inattentive (IN), hyperactive - impulsive (HI), and conduct disorder (CD) symptoms who develop nicotine dependence (A), alcohol use disorder (B), or cannabis use disorder (C) by 18 years of age.

Not exact matches

The increase in use disorders may be partially explained by an increase in the potency of cannabis products, said Beatriz Carlini, of the Alcohol and Drug Abuse Institute at the University of Washington in Seattle.
He has been outspoken about his social anxiety disorder and his cannabis use, even opening a line of weed gyms and more recently revealing a personal line of cannabis products.
Prior to this Act, cannabis was gaining popularity as a pharmaceutical - having been used for everything from pain to epilepsy to mental health disorders.
Yet marijuana is far less dangerous than many other drugs, and cannabis or its derivatives have been used to treat everything from chronic pain to post-traumatic stress disorder to childhood epilepsy.
These drugs may be used recreationally to purposefully alter one's consciousness (such as coffee, alcohol or cannabis), as entheogens for spiritual purposes (such as the mescaline - containing peyote cactus or psilocybin - containing mushrooms), and also as medication (such as the use of narcotics in controlling pain, stimulants to treat narcolepsy and attention disorders, as well as anti-depressants and anti-psychotics for treating neurological and psychiatric illnesses).
Medicinal cannabis use is booming for many disorders, the authors of the paper said, even without enough preclinical evidence or sufficient insights into its mechanism of action.
Researchers from Warwick Medical School found that adolescent cannabis use is an independent risk factor for future hypomania — periods of elated mood, over-active and excited behaviour, and reduced need for sleep that are often experienced as part of bipolar disorder, and have a significant impact on day - to - day life.
The findings suggest frequent adolescent cannabis use is likely to be a suitable target for interventions that may allay the risk of young people developing bipolar disorder.
However, the prospective link between cannabis use and bipolar disorder symptoms has rarely been investigated.
Two studies investigating the use of cannabis for spasticity and three case report on use for neuropathic pain, post-traumatic stress disorder or Tourette syndrome all lacked controls or blinding, conferring a high risk of biased findings.
«Depression among young teens linked to cannabis use at 18: Seattle - focused study suggests earlier intervention with depressed youths could reduce rate of cannabis - use disorder
What researchers called «a 1 standard deviation increase» in cumulative depression during early adolescence was associated with a 50 percent higher likelihood of cannabis - use disorder.
However, the review concluded that cannabis use might not be recommended for conditions such as bipolar disorder and psychosis.
Other research has shown that long - term use of cannabis increases adolescent drug users» risk for certain psychiatric and neurological disorders, such as schizophrenia.
Great post, I've had Graves Disease which is also an autoimmune disorder for over 10 yrs, about 5 years ago I completely stopped taking pharmaceuticals & replaced it with cannabis (personal choice to use as medication), cut out meat, dairy, processed foods, etc. & I was able to completely reverse my condition.
The website includes fact sheets on a range of topics from bullying to cannabis use and eating disorders.
Delusional - like experiences are more common in those with cannabis dependence disorder, very early - onset alcohol use or dependence disorders, and daily smokers
Box 3 also includes clinical judgements about compliance, whether alcohol or cannabis was currently used at clinically significant levels, and whether their use contributed to the onset of the psychotic disorders.
Cannabis use can be a significant contributor to poor mental health, particularly when it begins at a young age.4, 5 The adverse mental health effects of cannabis use in the general population are increasingly recognised, including anxiety, depression, 6 — 8 psychotic disorders, 4, 9 — 12 dependence6, 7, 13 withdrawal14, 15 and cognitive impairment.16, 17 Starting to use cannabis before age 15 is associated with an increased likelihood of developing later psychotic disorders, increased risk of dependence, other drug use, and poor educational and psychosocial ouCannabis use can be a significant contributor to poor mental health, particularly when it begins at a young age.4, 5 The adverse mental health effects of cannabis use in the general population are increasingly recognised, including anxiety, depression, 6 — 8 psychotic disorders, 4, 9 — 12 dependence6, 7, 13 withdrawal14, 15 and cognitive impairment.16, 17 Starting to use cannabis before age 15 is associated with an increased likelihood of developing later psychotic disorders, increased risk of dependence, other drug use, and poor educational and psychosocial oucannabis use in the general population are increasingly recognised, including anxiety, depression, 6 — 8 psychotic disorders, 4, 9 — 12 dependence6, 7, 13 withdrawal14, 15 and cognitive impairment.16, 17 Starting to use cannabis before age 15 is associated with an increased likelihood of developing later psychotic disorders, increased risk of dependence, other drug use, and poor educational and psychosocial oucannabis before age 15 is associated with an increased likelihood of developing later psychotic disorders, increased risk of dependence, other drug use, and poor educational and psychosocial outcomes.5
Two RCTs reported cannabis use outcomes following pharmacological interventions: one in people with major depression, alcohol dependence and cannabis abuse diagnoses (n = 22; fluoxetine vs placebo) and one in people with schizophrenia and cannabis and / or cocaine use disorders (n = 28; olanzapine vs risperidone).
Randomised controlled trials (RCTs) of pharmacological or psychological interventions reporting cannabis use outcomes in people with psychotic or depressive disorders were included in the review.
Do pharmacological or psychological interventions improve cannabis use outcomes in people with psychotic or depressive disorders?
For example, suffering childhood adversity, using cannabis, and having childhood viral infections of the central nervous system, all increase the odds of someone being diagnosed with a psychotic disorder (such as schizophrenia) by around two to threefold.
Continued cannabis use might increase the risk for psychotic disorder by impacting on the persistence of symptoms.
In the mental health field for more than 25 years with expertise in severe depression, psychosis, psychosis related to cannabis use, schizophrenia, borderline personality disorder, PTSD and bipolar disorder.
Substance use disorder was diagnosed as follows: cannabis in 10.1 % of the sample, alcohol in 3.4 % and other drugs in 0.4 %.
Objective: The purpose of this study was to provide nationally representative data on the prevalence, sociodemographic correlates, and comorbidity of antisocial syndromes across alcohol and 8 specific drug use disorders, including sedative, tranquilizer, opiate, stimulant, hallucinogen, cannabis, cocaine, and inhalant / solvent abuse and dependence.
Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community - based cohort.
After adjustment for sociodemographic factors, parental alcohol use and psychiatric disorders, and earlier externalizing and internalizing problems, substance use predicted criminality, especially among males, with the highest odds ratio (OR) for cannabis use [adjusted OR 6.2, 95 % confidence interval (CI) 3.1 — 12.7].
a b c d e f g h i j k l m n o p q r s t u v w x y z